Fertility and pregnancy in thalassemia major

Annals of the New York Academy of Sciences

Volumn 1054, Issue , 2005, Pages 300-307

  Tuck, Susan M ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Fertility; Pregnancy; thalassemia

Indexed keywords

ASCORBIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CHELATING AGENT; CLOMIFENE CITRATE; DEFEROXAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROCYTE ANTIBODY; ORAL ANTIDIABETIC AGENT;

BLOOD TRANSFUSION; CONFERENCE PAPER; FEMALE; FEMALE FERTILITY; HUMAN; HYPOGONADISM; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; PRENATAL CARE; THALASSEMIA MAJOR; UNITED KINGDOM; VITAMIN SUPPLEMENTATION;

EID: 29744465830     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1345.062     Document Type: Conference Paper

References (3)

1. JENSEN, C.E., S.M. TUCK, J. OLD, et al. 1997. Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with beta-thalassemia. Eur. J. Haematol. 59: 76-81.
2. TUCK, S.M., C.E. JENSEN, B. WONKE & A. YARDUMIAN. 1998. Pregnancy management and outcomes in women with thalassemia major. J. Pediatr. Endocrinol. Metab. 11: 923-928.
3. JENSEN, C.E., S.M. TUCK, J.E. AGNEW, et al. 1998. High prevalence of low bone mass in thalassemia major. Br. J. Haematol. 103: 911-915.